Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage IV Malignant Melanoma of Skin”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00938223
What this trial is testing

Evaluation of the Immunogenicity of Vaccination With Multiple Synthetic Melanoma Peptides With Granulocyte-macrophage Colony-stimulating Factor (GM-CSF)-In-Adjuvant, in Patients With Advanced Melanoma

Who this might be right for
Melanoma
Craig L Slingluff, Jr 51
Testing effectiveness (Phase 2)Study completedNCT01449279
What this trial is testing

Pilot Ipilimumab in Stage IV Melanoma Receiving Palliative Radiation Therapy

Who this might be right for
Melanoma
Stanford University 22
Early research (Phase 1)Study completedNCT02680184
What this trial is testing

Clinical Study of CMP-001 in Combination With Pembrolizumab or as a Monotherapy

Who this might be right for
Melanoma
Regeneron Pharmaceuticals 199
Early research (Phase 1)UnknownNCT00003747
What this trial is testing

Carboplatin and Temozolomide in Treating Patients With Unresectable or Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
Mount Vernon Cancer Centre at Mount Vernon Hospital 30
Early research (Phase 1)UnknownNCT00017355
What this trial is testing

Vaccine Therapy in Treating Patients With Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
Baylor Health Care System
Early research (Phase 1)Study completedNCT01657591
What this trial is testing

Study of XL888 With Vemurafenib for Patients With Unresectable BRAF Mutated Stage III/IV Melanoma

Who this might be right for
Melanoma
H. Lee Moffitt Cancer Center and Research Institute 21
Testing effectiveness (Phase 2)Study completedNCT00031733
What this trial is testing

Vaccine Therapy and Interleukin-12 With Either Alum or Sargramostim After Surgery in Treating Patients With Melanoma

Who this might be right for
Intraocular MelanomaMelanoma (Skin)
University of Southern California 60
Early research (Phase 1)Study completedNCT00655655
What this trial is testing

Everolimus and Vatalanib in Treating Patients With Advanced Solid Tumors

Who this might be right for
GastrinomaGlucagonomaInsulinoma+17 more
Mayo Clinic 96
Early research (Phase 1)Study completedNCT00091104
What this trial is testing

Cyclophosphamide and Fludarabine Followed by Vaccine Therapy, Gene-Modified White Blood Cell Infusions, and Aldesleukin in Treating Patients With Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
National Institutes of Health Clinical Center (CC) 136
Testing effectiveness (Phase 2)Study completedNCT03200847
What this trial is testing

Pembrolizumab and All-Trans Retinoic Acid Combination Treatment of Advanced Melanoma

Who this might be right for
Stage IV MelanomaStage III MelanomaAdvanced Melanoma
University of Colorado, Denver 26
Testing effectiveness (Phase 2)Study completedNCT00024011
What this trial is testing

PS-341 in Treating Patients With Metastatic Malignant Melanoma

Who this might be right for
Recurrent MelanomaStage IV Melanoma
National Cancer Institute (NCI) 50
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06708455
What this trial is testing

Phase 2b of RAPA-201 Cell Therapy in Post-PD-(L)-1 Melanoma

Who this might be right for
Malignant Melanoma With MetastasisMalignant MelanomaMalignant Melanoma Stage IIIc+1 more
Rapa Therapeutics LLC 65
Testing effectiveness (Phase 2)Ended earlyNCT02054520
What this trial is testing

Immunotherapy Study for Patients With Stage IV Melanoma

Who this might be right for
Stage IV MelanomaMetastatic Melanoma
NewLink Genetics Corporation 47
Testing effectiveness (Phase 2)Study completedNCT00085423
What this trial is testing

Cyclophosphamide, Fludarabine, and High-Dose Interleukin-2 in Treating Patients With Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
Dartmouth-Hitchcock Medical Center 20
Testing effectiveness (Phase 2)Study completedNCT02306850
What this trial is testing

Neoadjuvant Pembrolizumab for Unresectable Stage III and Unresectable Stage IV Melanoma

Who this might be right for
Unresectable Malignant NeoplasmMelanomaMetastatic Melanoma+2 more
St. Louis University 10
Testing effectiveness (Phase 2)Study completedNCT00019396
What this trial is testing

Flt3L With or Without Vaccine Therapy in Treating Patients With Metastatic Melanoma or Renal Cell Cancer

Who this might be right for
Stage IV MelanomaStage IV Renal Cell CancerRecurrent Renal Cell Cancer+1 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT01807182
What this trial is testing

Tumor-Infiltrating Lymphocytes After Combination Chemotherapy in Treating Patients With Metastatic Melanoma

Who this might be right for
Stage III Cutaneous Melanoma AJCC v7Stage IIIA Cutaneous Melanoma AJCC v7Stage IIIB Cutaneous Melanoma AJCC v7+3 more
Fred Hutchinson Cancer Center 11
Early research (Phase 1)Active Not RecruitingNCT02298959
What this trial is testing

Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced Cancer

Who this might be right for
Clinical Stage IV Cutaneous Melanoma AJCC v8Metastatic Colorectal CarcinomaMetastatic Malignant Solid Neoplasm+12 more
National Cancer Institute (NCI) 59
Very early researchStudy completedNCT01748747
What this trial is testing

Vaccine Therapy and Resiquimod in Treating Patients With Stage II-IV Melanoma That Has Been Removed By Surgery

Who this might be right for
Recurrent MelanomaStage IIA MelanomaStage IIB Melanoma+5 more
Mayo Clinic 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07576725
What this trial is testing

Low Dose, Reduced Frequency Nivolumab for the Treatment of Unresectable or Metastatic Cancer, AFFORD IO Trial

Who this might be right for
Clinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage III Cutaneous Merkel Cell Carcinoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8+40 more
Fred Hutchinson Cancer Center 50
Next Page